PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CORRECTED-GLOBAL MARKETS-Stocks keep spirits up before Fed meets

Tue, 16th Mar 2021 10:04

(Corrects U.S. 10-year Treasury yield to 1.6004%)

* Graphic: Global asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates http://tmsnrt.rs/2egbfVh

By Ritvik Carvalho

LONDON, March 16 (Reuters) - World stocks rose on Tuesday,
as investors anticipated the U.S. Federal Reserve and other
central banks meeting this week will keep policies accommodative
to help drive a post-pandemic global economic recovery.

European shares extended a rally that began on Wall Street
on Monday and continued into Asia, with the pan-region STOXX 600
index up 0.5%. On Monday, the index touched
its highest level in more than a year before ending flat.

Britain's FTSE 100 index rose 0.7%, Germany's DAX
0.6%, France's CAC 40 0.2% and Italy's FTSE MIB index
0.6%.

E-mini futures for the S&P 500 hit a record high
before trading flat on the day.

MSCI's All Country World Index, which tracks stocks across
49 countries, rose 0.2% to its highest levels since Feb 25.

An index of Asia-Pacific share markets excluding Japan
gained 0.65%, led by a 0.8% jump in Australia's
benchmark S&P/ASX 200 index.

Japan's Nikkei 225 gained 0.5% to just below the
30,000 mark. The broader Topix added 0.65%.

China's blue-chip CSI 300 index climbed 0.87% and
Hong Kong's Hang Seng gained 0.67%.

"The stock markets have kept their spirits up ahead of
tomorrow's important Fed announcement," said Karl Steiner, chief
quantitative strategist at SEB.

On Monday, the S&P 500 and Dow Jones Industrial Average both
soared on gains in travel stocks as mass vaccinations in the
United States and congressional approval of a $1.9 trillion aid
bill fueled investor optimism.

Longer-term U.S. Treasury yields slipped further on
Tuesday, as the market looked ahead to government debt auctions
and the Fed's two-day policy meeting, which will conclude on
Wednesday.

The benchmark 10-year yield, which reached a
more than one-year high of 1.642% last week, was back at
1.6004%.

The earlier surge in yields stemmed from investors
speculating that rising inflation expectations could prompt the
Federal Open Market Committee to signal it will start raising
rates sooner than expected.

"We think the FOMC will have a hard time expressing concern
about asset markets with the S&P at an all-time high on 12
March, despite 10Y U.S. Treasury yields at post-February 2020
highs," said analysts Steve Englander and John Davies at
Standard Chartered.

"Focus has been on the FOMC ‘dot plot’ in recent days, but
if the FOMC and Fed Chair (Jerome) Powell do not push back
against current yield levels, investors are likely to take
yields higher as better data arrives."

Fed policymakers are expected to forecast that the U.S.
economy will grow in 2021 by the fastest rate in decades, as it
recovers from a coronavirus-stricken 2020.

The Bank of England also meets this week on Thursday and the
Bank of Japan wraps up a two-day meeting on Friday.

On Wall Street, the Dow Jones Industrial Average rose
174.82 points, or 0.53%, to 32,953.46, the S&P 500 gained
25.6 points, or 0.65%, to 3,968.94 and the Nasdaq Composite
remained unchanged.

Airline shares rose as the companies pointed to
concrete signs of an industry recovery as vaccine rollouts help
spur leisure bookings.

The outlook for post-pandemic recoveries continued to
diverge between the U.S. and Europe.

President Joe Biden's order to make vaccination available to
all adults by May 1 contrasted with stuttering rollouts in
Germany, France and elsewhere, where use of the AstraZeneca
vaccine has been suspended amid concern over possible
side effects.

However, Kyle Rodda, an analyst at IG Markets, said the
prospect of a slower economic recovery in Europe didn't appear
to be a major handicap for investors.

"It doesn't seem to be the view that this is a real risk,"
he said. "Investors are wary, but not worried."

In currencies, the U.S. dollar held small gains from
overnight, with caution evident ahead of the central bank
meetings.

The dollar was largely flat at 109.19 yen, after
rising as high as 109.365 on Monday for the first time since
June.

The euro was little changed at $1.1930, holding for
an eighth session below the $1.20 level.

Bitcoin halted its slide from a record high of
$61,781.83 reached on Saturday, last trading 1% higher on the
day around $56,250.

U.S. West Texas Intermediate crude for April changed
hands at $64.74 a barrel, down 1%. Brent crude futures
for May stood at $68.22 a barrel, losing 1%.

(Reporting by Ritvik Carvalho; additional reporting by Kevin
Buckland and Kane Wu in Tokyo; editing by Larry King)

More News
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.